Intrahepatic Cholangiocarcinoma — Research

Intrahepatic Cholangiocarcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	7,290	`("Intrahepatic Cholangiocarcinoma"[tiab] OR "ICCA"[tiab] OR "Intrahepatic Bile Duct Carcinoma"[tiab] OR "Intrahepatic Carcinoma of Bile Duct"[tiab] OR "Intrahepatic Carcinoma of the Bile Duct"[tiab] OR "Intrahepatic Cholangiocellular Carcinoma"[tiab] OR "CHOLANGIOCARCINOMA, INTRAHEPATIC, MALIGNANT"[tiab] OR "Intrahepatic Bile Duct Cancer Cholangiocarcinoma"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	3,903	`("Intrahepatic Cholangiocarcinoma"[tiab] OR "ICCA"[tiab] OR "Intrahepatic Bile Duct Carcinoma"[tiab] OR "Intrahepatic Carcinoma of Bile Duct"[tiab] OR "Intrahepatic Carcinoma of the Bile Duct"[tiab] OR "Intrahepatic Cholangiocellular Carcinoma"[tiab] OR "CHOLANGIOCARCINOMA, INTRAHEPATIC, MALIGNANT"[tiab] OR "Intrahepatic Bile Duct Cancer Cholangiocarcinoma"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	894	`("Intrahepatic Cholangiocarcinoma"[tiab] OR "ICCA"[tiab] OR "Intrahepatic Bile Duct Carcinoma"[tiab] OR "Intrahepatic Carcinoma of Bile Duct"[tiab] OR "Intrahepatic Carcinoma of the Bile Duct"[tiab] OR "Intrahepatic Cholangiocellular Carcinoma"[tiab] OR "CHOLANGIOCARCINOMA, INTRAHEPATIC, MALIGNANT"[tiab] OR "Intrahepatic Bile Duct Cancer Cholangiocarcinoma"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (11)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–11 of 11 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.
· Lancet Oncol · 2020 · PMID 32203698 · validated civic_curation pubmed
GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma.
· Neoplasia · 2007 · PMID 17356712 · validated civic_curation pubmed
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
· Br J Cancer · 2019 · PMID 30420614 · validated civic_curation pubmed
Impressive response to dual BRAF and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma-2 case reports and a brief review.